ISO 13485

ISO 13485:2016 Certification Process: Medical Device Quality Management System (MDQMS)

ISO 13485:2016 is the internationally recognized benchmark standard for Quality Management Systems across the medical device industry. Specifically structured for regulatory compliance, it outlines requirements for organizations involved in one or more stages of the medical device lifecycle—including design and development, production, storage and distribution, installation, servicing, and the provision of associated parts and technical services.

Achieving accredited ISO 13485:2016 certification demonstrates to global regulatory authorities, healthcare providers, and supply chain partners that your organization consistently meets statutory, safety, and customer expectations.

The 8-Stage Certification Journey

Our accredited certification process is governed by ISO/IEC 17021-1 and international mandatory requirements (such as IAF MD 9) to ensure technical rigor, transparency, and global recognition.

Step 1: Application Review & Scope Classification

The process begins with completing the formal Certification Application. During this stage:

• Scope Definition: Your operational boundaries, manufacturing facilities, design activities, and device lines are evaluated.
• Technical Area Categorization: In accordance with IAF MD 9, your devices are classified into designated technical areas (e.g., Non-active Medical Devices, Active Devices, Active Implantables, In Vitro Diagnostics [IVD], Sterilization Processes, or Special Substances).
• Resource & Team Allocation: An audit duration is determined based on facility size, product risk classifications, regulatory jurisdictions, and effective personnel numbers. A qualified audit team and technical experts matching your product scope are formally assigned.

Step 2: Gap Analysis / Pre-Assessment (Optional)

Before entering the formal certification audits, organizations may opt for a preliminary pre-assessment:

• Identifies documentation gaps, system omissions, and compliance risks against ISO 13485 clauses.
• Evaluates organizational readiness prior to the binding Stage 1 and Stage 2 audits, providing a clear path to closure without issuing formal nonconformities.

Step 3: Stage 1 Audit (Readiness & Documentation Review)

The Stage 1 audit evaluates system architecture and documentation completeness:

• Quality Manual & Procedural Review: Verification of mandatory ISO 13485 documented procedures, Device Master Records (DMR), and Medical Device Files (MDF).
• Risk Management Evaluation: Review of risk management frameworks aligned with ISO 14971 principles across the product lifecycle.
• Regulatory Compliance Check: Assessment of processes established to meet applicable statutory requirements (e.g., national regulatory filings, post-market surveillance plans, and adverse event reporting protocols).
• Internal Audits & Management Review: Confirmation that at least one full cycle of internal audits and top management reviews has been executed.
• Stage 2 Readiness: The Lead Auditor issues a formal Stage 1 report confirming whether the system is sufficiently mature to progress to Stage 2.

Step 4: Stage 2 Audit (On-Site Implementation & Performance)

The Stage 2 audit is an in-depth evaluation of operational practices at your physical and manufacturing sites:

• Design & Development Controls: Traceability of design inputs, design verification/validation, risk reviews, and design transfer files.
• Cleanroom, Environmental & Contamination Controls: Environmental monitoring, particulate testing, bioburden controls, and hygiene standards where applicable.
• Process Validation & Equipment Qualification: Verification of IQ/OQ/PQ protocols for critical production lines, software tools, and sterilization methods.
• Traceability, Identification & Labelling: Lot/batch traceability from raw material suppliers through final packaging, labelling, and Unique Device Identification (UDI) c
• Corrective & Preventive Action (CAPA): Deep review of complaint handling, root cause investigations, nonconforming product dispositions, and field corrective actions.

Step 5: Findings Closure & Corrective Action

At the conclusion of the Stage 2 audit, the audit team presents findings during the formal closing meeting:

• Opportunities for Improvement (OFIs): Observations to support continual system optimization.
• Minor Nonconformities: Requiring a documented Corrective Action Plan (CAP) and root cause analysis within a specified timeline.
• Major Nonconformities: Requiring immediate correction, root-cause resolution, and verification (which may include a focused follow-up audit) prior to certificate approval.

Step 6: Independent Technical Review & Certificate Issuance

To safeguard impartiality, the complete audit package is submitted to an independent technical review committee:

• The review panel verifies that the audit team possessed the appropriate technical competencies, covered all applicable technical areas, and that all findings are closed satisfactorily.
• Upon approval, an accredited ISO 13485:2016 Certificate of Registration is issued, complete with recognized accreditation body marks.
• The certificate is valid for a 3-year cycle, subject to ongoing annual surveillance compliance.

Step 7: Surveillance Audits (Years 1 & 2)

Accredited standards require routine surveillance evaluations to ensure the QMS remains compliant and effective:

• Cadence: Conducted at least once per calendar year (typically at Month 12 and Month 24 following the initial certification).
• Focus Areas: Review of customer complaints, regulatory reporting, post-market clinical follow-up data, changes to device designs or production lines, CAPA logs, and selected core clauses.

Step 8: Recertification Audit (Year 3)

Approximately three to six months prior to the expiration of the 3-year certificate, a recertification audit is initiated:

• Evaluates the overall performance and sustained maturity of the QMS across the entire 3-year cycle.
• Upon successful completion, a new accredited certificate is issued for another 3-year period.

Primary Benefits of ISO 13485 Certification

• Global Market Access: Simplifies market approvals and regulatory licensing across the European Union (CE Mark / MDR), United Kingdom (UKCA), United States (FDA 21 CFR Part 820 / QMSR alignment), and global healthcare procurement markets.
• Operational Risk Reduction: Systematic hazard identification, traceability, and process validation minimize batch failures, product recalls, and liability exposure.
• Customer & Tender Confidence: Satisfies mandatory supplier qualification criteria for international hospital networks, medical equipment distributors, and government tenders.
• Supply Chain Credibility: Streamlines vendor onboarding by providing objective, third-party verification of your quality systems.